JPY 2454.0
(1.95%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 75.72 Billion JPY | 10.74% |
2022 | 68.38 Billion JPY | 14.87% |
2021 | 59.53 Billion JPY | 7.4% |
2020 | 55.43 Billion JPY | -8.28% |
2019 | 60.43 Billion JPY | -2.25% |
2018 | 61.82 Billion JPY | -4.26% |
2017 | 64.57 Billion JPY | -0.44% |
2016 | 64.86 Billion JPY | 3.81% |
2015 | 62.47 Billion JPY | 2.32% |
2014 | 61.06 Billion JPY | -1.5% |
2013 | 61.99 Billion JPY | 16.25% |
2012 | 53.32 Billion JPY | 0.25% |
2011 | 53.19 Billion JPY | 7.43% |
2010 | 49.51 Billion JPY | -2.46% |
2009 | 50.76 Billion JPY | 6.49% |
2008 | 47.66 Billion JPY | -4.19% |
2007 | 49.75 Billion JPY | -5.7% |
2006 | 52.76 Billion JPY | -5.04% |
2005 | 55.56 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 21.45 Billion JPY | 20.49% |
2023 Q1 | 18.3 Billion JPY | 9.91% |
2023 FY | 75.72 Billion JPY | 10.74% |
2023 Q3 | 21.24 Billion JPY | 15.6% |
2023 Q2 | 18.37 Billion JPY | 0.38% |
2023 Q4 | 17.8 Billion JPY | -16.17% |
2022 Q3 | 18.01 Billion JPY | 3.5% |
2022 Q1 | 16.3 Billion JPY | 13.01% |
2022 FY | 68.38 Billion JPY | 14.87% |
2022 Q4 | 16.65 Billion JPY | -7.57% |
2022 Q2 | 17.4 Billion JPY | 6.76% |
2021 Q3 | 16.49 Billion JPY | 9.57% |
2021 FY | 59.53 Billion JPY | 7.4% |
2021 Q1 | 13.54 Billion JPY | 3.67% |
2021 Q2 | 15.05 Billion JPY | 11.13% |
2021 Q4 | 14.42 Billion JPY | -12.55% |
2020 Q3 | 15.55 Billion JPY | 15.48% |
2020 FY | 55.43 Billion JPY | -8.28% |
2020 Q1 | 13.33 Billion JPY | -5.71% |
2020 Q4 | 13.06 Billion JPY | -15.99% |
2020 Q2 | 13.47 Billion JPY | 1.04% |
2019 Q4 | 14.14 Billion JPY | -11.49% |
2019 Q3 | 15.97 Billion JPY | 5.07% |
2019 Q2 | 15.2 Billion JPY | 0.63% |
2019 FY | 60.43 Billion JPY | -2.25% |
2019 Q1 | 15.11 Billion JPY | 3.34% |
2018 FY | 61.82 Billion JPY | -4.26% |
2018 Q4 | 14.62 Billion JPY | -12.56% |
2018 Q3 | 16.72 Billion JPY | 9.86% |
2018 Q2 | 15.22 Billion JPY | -0.22% |
2018 Q1 | 15.25 Billion JPY | 2.04% |
2017 Q4 | 14.95 Billion JPY | -13.2% |
2017 FY | 64.57 Billion JPY | -0.44% |
2017 Q3 | 17.22 Billion JPY | 4.82% |
2017 Q2 | 16.43 Billion JPY | 2.9% |
2017 Q1 | 15.96 Billion JPY | 0.83% |
2016 Q2 | 15.82 Billion JPY | -4.04% |
2016 Q1 | 16.48 Billion JPY | 6.79% |
2016 Q4 | 15.83 Billion JPY | -5.23% |
2016 Q3 | 16.71 Billion JPY | 5.63% |
2016 FY | 64.86 Billion JPY | 3.81% |
2015 Q3 | 16.69 Billion JPY | 6.96% |
2015 Q1 | 14.72 Billion JPY | -3.71% |
2015 FY | 62.47 Billion JPY | 2.32% |
2015 Q4 | 15.43 Billion JPY | -7.54% |
2015 Q2 | 15.61 Billion JPY | 6.0% |
2014 FY | 61.06 Billion JPY | -1.5% |
2014 Q3 | 15.62 Billion JPY | 1.38% |
2014 Q2 | 15.41 Billion JPY | 4.65% |
2014 Q1 | 14.72 Billion JPY | -3.51% |
2014 Q4 | 15.29 Billion JPY | -2.1% |
2013 FY | 61.99 Billion JPY | 16.25% |
2013 Q4 | 15.26 Billion JPY | -8.23% |
2013 Q3 | 16.63 Billion JPY | 12.68% |
2013 Q2 | 14.75 Billion JPY | -3.77% |
2013 Q1 | 15.33 Billion JPY | 17.6% |
2012 Q3 | 14.34 Billion JPY | 9.84% |
2012 Q4 | 13.04 Billion JPY | -9.11% |
2012 Q2 | 13.06 Billion JPY | 1.52% |
2012 FY | 53.32 Billion JPY | 0.25% |
2012 Q1 | 12.86 Billion JPY | 7.16% |
2011 Q1 | 13.46 Billion JPY | 14.28% |
2011 FY | 53.19 Billion JPY | 7.43% |
2011 Q2 | 13.11 Billion JPY | -2.57% |
2011 Q3 | 14.6 Billion JPY | 11.3% |
2011 Q4 | 12 Billion JPY | -17.76% |
2010 Q1 | 11.7 Billion JPY | -8.5% |
2010 Q4 | 11.78 Billion JPY | -9.05% |
2010 Q2 | 13.06 Billion JPY | 11.59% |
2010 FY | 49.51 Billion JPY | -2.46% |
2010 Q3 | 12.95 Billion JPY | -0.86% |
2009 Q4 | 12.79 Billion JPY | -6.54% |
2009 Q3 | 13.69 Billion JPY | 8.23% |
2009 Q2 | 12.65 Billion JPY | 8.89% |
2009 Q1 | 11.61 Billion JPY | -2.7% |
2009 FY | 50.76 Billion JPY | 6.49% |
2008 Q2 | 12.77 Billion JPY | 0.0% |
2008 Q3 | 11.58 Billion JPY | -9.27% |
2008 FY | 47.66 Billion JPY | -4.19% |
2008 Q4 | 11.94 Billion JPY | 3.03% |
2007 FY | 49.75 Billion JPY | -5.7% |
2006 FY | 52.76 Billion JPY | -5.04% |
2005 FY | 55.56 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -21.848% |
Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 98.224% |
Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 75.927% |
Shionogi & Co., Ltd. | 435.08 Billion JPY | 82.595% |
Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -878.559% |
Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | 48.922% |
Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -5.109% |
Eisai Co., Ltd. | 741.75 Billion JPY | 89.791% |
Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -510.391% |
Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | 46.562% |
Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | 26.398% |
Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -36.673% |
Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -146.276% |
Tsumura & Co. | 150.84 Billion JPY | 49.799% |
Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -0.193% |
Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -38.594% |
Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 66.778% |
Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -85.197% |
KYORIN Holdings, Inc. | 119.53 Billion JPY | 36.649% |
Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -1402.482% |
Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -61.478% |
SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -1254.723% |
MedRx Co., Ltd | 26 Million JPY | -291150.288% |
Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -589.053% |
Solasia Pharma K.K. | 617 Million JPY | -12173.108% |
Modalis Therapeutics Corporation | - JPY | -Infinity% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -20.499% |
Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 57.184% |
Cyfuse Biomedical K.K. | 61.11 Million JPY | -123811.957% |
Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 94.872% |
Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -242.119% |